Anticoagulants: Tests for Checking Bleeding Unreliable?
“Blood thinners are helpful drugs and we do not want people to stop taking them,” says Henry Spiller, MS, D.ABAT, a co-author of the study, toxicologist, and director of the Central Ohio Poison Center at Nationwide Children’s Hospital. “We may need to get better about how we monitor patients on these drugs.”
Data from more than 800 hospitals and eight regional poison centres covering nine states were used for this retrospective study. Of the 223 patients included in the study, bleeding was reported in only 15 patients (7 percent): 11 rivaroxaban and 4 apixaban. Coagulation tests were normal in most patients with bleeding (PT 83 percent, PTT 83 percent and INR 44 percent).
According to the research team, PT was shown to be elevated in volunteer studies with rivaroxaban and also elevated in massive overdose. However, results of the PT after use of blood thinners varied with different components. The effects of medications on PTT are short lived and varies based on the reagents used. In patients with bleeding, PT and PTT were elevated in 1 of 4 with rivaroxaban and none with apixaban. Without specific clarification of methodology and reagent use, the researchers say, the PT and PTT may not reliably predict risk of bleeding after rivaroxaban or apixaban ingestion.
The measurement of INR with rivaroxaban has also been questioned because the INR does not correct for the variations in PT based on which reagent was used. As shown in volunteer studies, the INR was elevated in only 21 percent of patients tested with rivaroxaban and in no patients with apixaban. In patients with bleeding, the INR was elevated in 5 of 8 with rivaroxaban but in none with apixaban. Without specific clarification of methodology and reagent use, the INR may also be an unreliable test after rivaroxaban or apixaban ingestion. In addition, the use of activated clotting time appears to be insensitive after Xa inhibitor use, says the research team.
“One way to overcome the variation in these tests is to use anti-factor Xa chromogenic assays to measure Xa plasma concentrations; however these are not widely available,” Spiller points out. “And a potential drawback with measuring anti-factor Xa concentrations and plasma rivaroxaban and apixaban concentrations is that the turnaround time for results may be too long to guide a treatment plan.”
Source and image credit: Nationwide Children's Hospital
Published on : Thu, 27 Aug 2015
Right when it matters. Right where it counts. Simplify assessments and deliver effective care with Venue Go. Featuring a uniquely adaptable design that goes from cart to table to wall, Venue Go supports Point of Care medicine across...
Especially developed for long-term lung support. This patient kit includes a powerful membrane lung, the DP3 pump head, safe integrated pressure sensors (IPS) and a CRRT connector. One vascular access offers the possibility to combine the therapies for...
Intended for emergency airway access when conventional endotracheal intubation cannot be performed. Features and benefits The catheter is coil reinforced to prevent kinking. Emergency Transtracheal Airway Catheter procedural...
Closed System Gastric Residuals Aspiration and Measurement Accessory More details, please check the video here
The iLA membrane ventilator is an extrapulmonary ventilation system which is used to remove carbon dioxide. The heart pumps blood through the iLA membrane ventilator as it does through a natural organ. The iLA membrane ventilator “breathes” outside...